# Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine

> **NCT01813292** · — · COMPLETED · sponsor: **Hopital Lariboisière** · enrollment: 103 (actual)

## Conditions studied

- HIV Seropositivity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01813292
- **Lead sponsor:** Hopital Lariboisière
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-05
- **Final completion:** 2014-07
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2016-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01813292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01813292, "Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01813292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*